LEXEO THERAPEUTICS INC (LXEO) Stock Cash Flow
NASDAQ:LXEO - US52886X1072 - Common Stock
4.85 USD
-0.04 (-0.82%)
4.85 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -114.17M | -98.33M | -66.39M | -59.28M | -50.62M | |||
| Depreciation Amortization | 2.04M | 2.00M | 1.84M | 270.00K | 10.00K | |||
| Change In Working Capital | 6.37M | 2.73M | 1.48M | 1.79M | 6.04M | |||
| Interest Paid | N/A | 127.00K | N/A | N/A | N/A | |||
| Other non cash items | 10.70M | 12.45M | 3.57M | 2.66M | 390.00K | |||
| OPERATING CASH FLOW | -95.09M | -81.15M | -59.50M | -54.56M | -44.18M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -481.00K | -165.00K | -900.00K | -190.00K | |||
| Other Investing Activity | N/A | -93.60M | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -117.24M | -94.08M | -165.00K | -900.00K | -190.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -511.00K | -410.00K | 3.58M | -160.00K | 0.00 | |||
| Stock Issued/Repurchased | 80.36M | 89.19M | 51.00K | 350.00K | 151.23M | |||
| Other Financing Activity | N/A | N/A | 100.17M | 0.00 | -370.00K | |||
| FINANCING CASH FLOW | 72.75M | 88.78M | 103.79M | 190.00K | 150.86M | |||
| CHANGE IN CASH | -139.58M | -86.45M | 44.13M | -55.27M | 106.49M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -95.09M | -81.15M | -59.50M | -54.56M | -44.18M | |||
| Capital Expenditure | N/A | -481.00K | -165.00K | -900.00K | -190.00K | |||
| FREE CASH FLOW | -95.27M | -81.63M | -59.66M | -55.46M | -44.37M | |||
All data in USD